Product image of Glimepiride Cf (Glimepiride) supplied by GNH India

Glimepiride Cf

Active Ingredient:
Glimepiride
Origin:
EU

Glimepiride Cf (Glimepiride)

Glimepiride Cf is a generic oral medication that contains the active ingredient glimepiride, a sulfonylurea antidiabetic agent. It is supplied as tablets for oral use and is marketed in the European Union as a prescription‑only product. The drug is indicated to improve blood‑glucose control in adults with type 2 diabetes mellitus by stimulating insulin release from pancreatic beta cells and may be combined with lifestyle measures.

Manufacturer / TM Owner

Centrafarm B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glimepiride Cf is prescribed for the management of type 2 diabetes mellitus in adults.

  • As monotherapy when diet and exercise are insufficient.
  • In combination with metformin when additional glucose lowering is needed.
  • As part of a comprehensive diabetes treatment plan that includes lifestyle modification.
  • For patients whose glycemic control requires a sulfonylurea agent.

Side Effects

Side effects of Glimepiride Cf vary in frequency and severity.

Common

  • Hypoglycemia (low blood sugar).
  • Weight gain.
  • Nausea or abdominal discomfort.
  • Headache.
  • Dizziness.
  • Mild rash.

Serious

  • Severe hypoglycemia requiring assistance.
  • Allergic reactions such as angioedema or severe rash.
  • Blood dyscrasias (e.g., leukopenia, thrombocytopenia).
  • Hepatic dysfunction or jaundice.

Precautions & Warnings

Before starting Glimepiride Cf, certain precautions should be considered.

  • Assess renal and hepatic function; dose may need adjustment.
  • Use caution in elderly patients due to increased hypoglycemia risk.
  • Avoid in patients with known sulfonylurea hypersensitivity.
  • Monitor blood glucose regularly to detect hypoglycemia.
  • Pregnancy and lactation status should be evaluated; safety data are limited.
  • Review concomitant use of other glucose‑lowering agents.

Avoid Interactions

Glimepiride Cf can interact with several medicines, affecting its efficacy or safety.

Avoid

  • Other sulfonylureas or insulin (additive hypoglycemia risk).
  • Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) which increase glimepiride levels.
  • MAO‑B inhibitors (e.g., selegiline) may potentiate hypoglycemia.

Use with caution

  • Beta‑blockers (may mask hypoglycemia symptoms).
  • Thiazide diuretics (may reduce glucose‑lowering effect).
  • NSAIDs (may affect renal function and glucose control).
  • Certain antidepressants such as SSRIs (potential for altered glycemic control).

Frequently Asked Questions

Glimepiride Cf stimulates insulin release from pancreatic beta cells by closing ATP‑sensitive potassium channels, which enhances glucose uptake and lowers blood sugar.

By increasing endogenous insulin secretion, Glimepiride Cf improves post‑prandial and fasting glucose levels, supporting overall glycemic control.

Yes, Glimepiride Cf is often combined with metformin when additional glucose‑lowering effect is required, but the combination should be prescribed by a healthcare professional.

Common side effects include hypoglycemia, weight gain, nausea, headache, dizziness, and mild skin rash.

Serious reactions such as severe hypoglycemia, allergic swelling, blood‑cell abnormalities, or signs of liver injury require immediate medical attention.

Elderly individuals have a higher risk of hypoglycemia; dose adjustments and close glucose monitoring are recommended.

Glimepiride Cf is usually taken once daily with breakfast, but exact timing should follow the prescribing clinician’s instructions.

Avoid concurrent use of other sulfonylureas, insulin, strong CYP2C9 inhibitors, and MAO‑B inhibitors because they can increase the risk of hypoglycemia.

Safety data are limited; the drug should only be used during pregnancy or lactation if the potential benefit justifies the potential risk and after consulting a healthcare provider.

Regular blood glucose checks, periodic assessment of renal and hepatic function, and monitoring for signs of hypoglycemia are advised.

Yes, impaired kidney or liver function may require dose reduction or alternative therapy to avoid accumulation and hypoglycemia.

Glimepiride has a longer duration of action and a lower risk of hypoglycemia compared with some older sulfonylureas, but individual response can vary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glimepiride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT